Recent Patents on Permeation Enhancers for Drug Delivery Through Nails

Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..

The human nail is a unique barrier with a keratinized constitution that favors protection and fine touch. However, many disorders can affect the nail, among them, are the onychomycosis and psoriasis. Systemic oral therapy has been applied to treat these diseases, even presenting disadvantages, including side effects, drug interactions, contraindications, toxicity, high cost and low patient compliance. A great option to succeed in dealing with the problems associated with oral therapy is the topical administration of drugs. However, nail composition, low diffusion through ungual route and reduced tissue bioavailability for topical treatments are limiting factors. These drawbacks can be overcome by promoting penetration through the nails by employing penetration enhancers. The review focuses on patents that highlight permeation enhancers applied to nail drug delivery for the treatment of onychomycosis and psoriasis. Literature and patent searches were conduced regarding the topic of interest. The substantial literature and patent search revealed that permeation enhancers, especially chemicals, are great strategies for promoting the ungual delivery of drugs. Nail topical therapy containing permeation enhancers is an attractive option for delivering localized treatments.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

Recent patents on drug delivery & formulation - 13(2019), 3 vom: 17., Seite 203-218

Sprache:

Englisch

Beteiligte Personen:

Kreutz, Tainá [VerfasserIn]
de Matos, Sheila Porto [VerfasserIn]
Koester, Letícia Scherer [VerfasserIn]

Links:

Volltext

Themen:

Journal Article
Nail drug delivery
Onychomycosis
Patent
Permeation enhancer
Pharmaceutical Preparations
Psoriasis
Review
Ungual drug delivery.

Anmerkungen:

Date Completed 24.07.2020

Date Revised 13.11.2023

published: Print

Citation Status MEDLINE

doi:

10.2174/1872211313666191030155837

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM302684379